Trial Profile
A retrospective study of neoadjuvant Denosumab in locally advanced giant cell tumor of bone patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Jun 2017
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Bone cancer; Giant cell tumours
- Focus Therapeutic Use
- 06 Jun 2017 New trial record
- 02 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology